Atlas Trials

Nivolumab Plus Metformin in Metastatic Renal Cell Carcinoma

Clinical trial NCT06884683 · TERMINATED

Trial details

NCT number
NCT06884683
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Renal Cell Carcinoma
Start date
2020-09-17
Primary completion
2023-09-13
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.